**Bruker Launches iNTApharma™ Platform for Nanoparticle Analysis in mRNA and Gene Therapy**
Bruker has announced the release of iNTApharma™, a new label-free platform designed to characterize nanoparticles used in mRNA drug development and gene therapy quality control. The technology aims to provide detailed analysis of nanoparticle size, concentration, and stability without the need for fluorescent or radioactive labels. The platform is intended …